Skip to content
Lower risk Drug recall · FDA · Published August 7, 2018

PD-Rx Doxycycline Tablets Recall: Failed Dissolution Risk

PD-Rx Pharmaceuticals recalls 100mg Doxycycline Hyclate tablets with failed dissolution tests. These may not work as intended. Check NDC codes and expiration dates for affected lots.

🇺🇸 FDA recall #D-1127-2018DrugPD-Rx Pharmaceuticals ›
Take action

Contact the company

Recalling firmPD-Rx Pharmaceuticals, Inc.727 N Ann Arbor Ave · Oklahoma City, OK 73127-5822
✎ GovInfoNow plain-language explainer

PD-Rx Pharmaceuticals is recalling certain 100mg Doxycycline Hyclate tablets due to failed dissolution tests. This means the medication may not dissolve properly in the body, reducing effectiveness. Affected products were sold with specific NDC codes and expiration dates. Read more at govinfonow.com/recall/39752-pd-rx-doxycycline-tablets-recall-failed-dissolution-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/39752-pd-rx-doxycycline-tablets-recall-failed-dissolution-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-1127-2018

Cite this page

“PD-Rx Doxycycline Tablets Recall: Failed Dissolution Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39752-pd-rx-doxycycline-tablets-recall-failed-dissolution-risk. Based on FDA recall #D-1127-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1127-2018%22&limit=1).

The FDA announced on 2018-08-07 that PD-Rx Pharmaceuticals, Inc. recalled Doxycycline Hyclate USP Tablets due to failed dissolution specifications. The agency stated the recall was voluntary and initiated by the firm.

How to tell if you have it

  • Brand: PD-Rx Pharmaceuticals
  • Product: Doxycycline Hyclate USP Tablets, 100 mg
  • Packaging: 2-count (NDC 55289-866-02), 6-count (NDC 55289-866-06), 7-count (NDC 55289-866-07), 10-count (NDC 55289-866-10), 14-count (NDC 55289-866-14), 20-count (NDC 55289-866-20), 28-count (NDC 55289-866-28), 30-count (NDC 55289-866-30), 120-count (NDC 55289-866-98), 300-count (NDC 55289-866-87), 400-count (NDC 55289-866-74)
  • Lot codes: D17D29, L17C73, F18E73, H17D70, K17F66, G18F26, C18G26, F18E36, F18A85, K17B44, K17E29, L17D93, E17B88, H17A52, H17D67, E17B01, E17E83, F17C99, G17C08, G17E18, H17B01, H17B66, H17F67, I17A56, E17E27, I17A33, G17D62, E17B35, E17D90, F17C13, G17B25, H17C58, G17D59, I17A69, G17D58, G17D56
  • Expiration dates: 1/31/19, 5/31/19, 6/30/19, 7/31/19
  • Quantity: 6,641 bottles
  • Distribution: Nationwide in the USA

The hazard

The recall was issued because manufacturer West-Ward Pharm Corp. obtained failed dissolution results for these repackaged lots. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show PD-Rx Pharmaceuticals, Inc. has 16 other recalls on record since 2015-04-29. Other recent recalls of similar products include PD-Rx DULoxetine 30mg 90-count recall (2024-12-04), PD-Rx Simvastatin 10mg Recall (2023-04-06), and PD-Rx Losartan Tablets Recall (2022-06-06). Other recent recalls of similar products include Ascend Minocycline Tablets Recall (2026-06-01), Inventia Healthcare Chlorthalidone Tablets Recall (2026-06-05), and Ajanta Pharma Recalls Ranolazine 1000mg Due to Dissolution Failure (2026-09-17).

How to tell if you have this one

Check for NDC codes: 55289-866-02 to 55289-866-98. Also look for expiration dates listed in the recall notice (e.g., 1/31/19, 5/31/19, 7/31/19).

  • Brand
    PD-Rx Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for NDC codes 55289-866-02 through 55289-866-98 and expiration dates listed in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Aug 7, 201812. FDA classified it Class II: Aug 24, 201823. Published in FDA’s Enforcement Report: Sep 5, 201834. FDA terminated the recall: May 7, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have these tablets?

Check the NDC codes and expiration dates listed in the recall notice to see if your product is affected. If it is, contact your healthcare provider for advice.

Are there any safety risks from using these tablets?

The recall is due to potential reduced effectiveness, not immediate safety risks. There is no risk of serious injury or harm from using these tablets.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1127-2018 (August 7, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1127-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA